Browse by UCL people
Group by: Type | Date
Number of items: 55.
2025
|
Arenas-Pinto, Alejandro;
Abrescia, Nicola;
Abdel-Hameed, Enass A;
(2025)
Metabolic dysfunction-associated steatotic liver disease and liver fibrosis in people with HIV.
AIDS
, 39
(12)
pp. 1822-1824.
10.1097/QAD.0000000000004287.
|
2024
Moore, Amelia EB;
Burns, James E;
Sally, Deirdre;
Milinkovic, Ana;
Krokos, Georgios;
John, Joemon;
Rookyard, Christopher;
... Pett, Sarah L; + view all
(2024)
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV.
AIDS
, 38
(4)
pp. 521-529.
10.1097/QAD.0000000000003811.
|
|
Paredes, JL;
Arenas-Pinto, A;
McAlpine, C;
Matthews, R;
Milinkovic, A;
Suonpera, E;
(2024)
Depression is associated with poor self-reported adherence to antiretroviral therapy among people living with HIV attending an HIV clinic in the UK: results from a cross-sectional study.
AIDS Care
, 36
(10)
pp. 1392-1399.
10.1080/09540121.2024.2303969.
|
2023
|
Ahmed, N;
Herbert, S;
Arenas-Pinto, A;
Rickman, H;
Benn, P;
Edwards, SG;
Chiodini, PL;
(2023)
Trypanosoma cruzi screening in people living with HIV in the UK.
International Journal of STD and AIDS
10.1177/09564624231202292.
(In press).
|
|
Arenas-Pinto, A;
Bakewell, N;
Milinkovic, A;
Williams, I;
Vera, J;
Post, FA;
Anderson, J;
... Sabin, CA; + view all
(2023)
Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohort.
HIV Medicine
10.1111/hiv.13540.
(In press).
|
|
Clement, Clare;
Coulman, Karen;
Heywood, Nick;
Pinkney, Tom;
Blazeby, Jane;
Blencowe, Natalie S;
Cook, Jonathan Alistair;
... Lane, J Athene; + view all
(2023)
How surgical Trainee Research Collaboratives achieve success: a mixed methods study to develop trainee engagement strategies.
BMJ Open
, 13
(12)
, Article e072851. 10.1136/bmjopen-2023-072851.
|
|
Lundgren, Jens D;
Babiker, Abdel G;
Sharma, Shweta;
Grund, Birgit;
Phillips, Andrew N;
Matthews, Gail;
Kan, Virginia L;
... INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Stu; + view all
(2023)
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.
NEJM Evidence
, 2
(3)
10.1056/evidoa2200302.
|
 |
|
MacDonald, DM;
Samorodnitsky, S;
Wendt, CH;
Baker, JV;
Collins, G;
Kruk, M;
Lock, EF;
... León, M; + view all
(2023)
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV.
Scientific Reports
, 13
(1)
, Article 4749. 10.1038/s41598-023-29739-x.
|
|
Safo, Sandra E;
Haine, Lillian;
Baker, Jason;
Reilly, Cavan;
Duprez, Daniel;
Neaton, James D;
Jain, Mamta K;
... ESPRIT, INSIGHT FIRST, SMART and START study groups; + view all
(2023)
Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort.
Journal of the American Heart Association
, 12
, Article e027273. 10.1161/JAHA.122.027273.
|
2022
|
Arenas-Pinto, Alejandro;
Judd, Ali;
Melvin, Diane;
Le Prevost, Marthe;
Foster, Caroline;
Sturgeon, Kate;
Winston, Alan;
... Adolescents and Adults Living with Perinatal HIV (AALPHI) Steeri; + view all
(2022)
Learning and memory function in young people with and without perinatal HIV in England.
PLoS One
, 17
(9)
, Article e0273645. 10.1371/journal.pone.0273645.
|
|
Guest, C;
Dewhirst, SY;
Lindsay, SW;
Allen, DJ;
Aziz, S;
Baerenbold, O;
Bradley, J;
... Allsop, L; + view all
(2022)
Using trained dogs and organic semi-conducting sensors to identify asymptomatic and mild SARS-CoV-2 infections: an observational study.
Journal of Travel Medicine
, 29
(3)
, Article taac043. 10.1093/jtm/taac043.
|
|
Jones, TPW;
Lampe, FC;
Arenas-Pinto, A;
Smith, C;
McDonnell, J;
Haddow, L;
Johnson, M;
... Rodger, AJ; + view all
(2022)
Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross-sectional and longitudinal analyses.
HIV Medicine
, 23
(3)
pp. 209-226.
10.1111/hiv.13156.
|
2021
|
Fernández, I;
De Lazzari, E;
Inciarte, A;
Diaz-Brito, V;
Milinkovic, A;
Arenas-Pinto, A;
Etcheverrry, F;
... Gatell, JM; + view all
(2021)
Network meta‐analysis of post‐exposure prophylaxis randomized clinical trials.
HIV Medicine
, 22
(3)
pp. 218-224.
10.1111/hiv.12964.
|
|
Gabrielaite, M;
Bennedbæk, M;
Zucco, AG;
Ekenberg, C;
Murray, DD;
Kan, VL;
Touloumi, G;
... INSIGHT START trial group; + view all
(2021)
Human immunotypes impose selection on viral genotypes through viral epitope specificity.
The Journal of Infectious Diseases
, Article jiab253. 10.1093/infdis/jiab253.
(In press).
|
|
Hall, VJ;
Foulkes, S;
Charlett, A;
Atti, A;
Monk, EJ;
Simmons, R;
Wellington, E;
... SIREN Study Group, .; + view all
(2021)
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
Lancet
, 397
(10283)
10.1016/S0140-6736(21)00675-9.
|
|
|
Hall, VJ;
Foulkes, S;
Saei, A;
Andrews, N;
Oguti, B;
Charlett, A;
Wellington, E;
... SIREN Study Group; + view all
(2021)
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.
Lancet
, 397
(10286)
pp. 1725-1735.
10.1016/S0140-6736(21)00790-X.
|
|
|
Pyrć, K;
Milewska, A;
Duran, EB;
Botwina, P;
Dabrowska, A;
Jedrysik, M;
Benedyk, M;
... Uchegbu, IF; + view all
(2021)
SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray.
Scientific Reports
, 11
, Article 20012. 10.1038/s41598-021-99404-8.
|
|
2020
|
Arenas-Pinto, A;
Stöhr, W;
Khoo, S;
Clarke, A;
Beeching, N;
Warwick, Z;
Lee, V;
... Protease Inhibitor monotherapy Versus Ongoing Triple therapy (PI; + view all
(2020)
Genital secretion HIV RNA shedding in HIV-positive patients on ritonavir-boosted protease inhibitor monotherapy or standard combination ART: a cross-sectional sub-study from the PIVOT Trial.
Antiviral Therapy
10.3851/IMP3340.
(In press).
|
|
|
Judd, A;
Melvin, D;
Thompson, LC;
Foster, C;
Le Prevost, M;
Evangeli, M;
Winston, A;
... Castro, H; + view all
(2020)
Factors Associated With Nonadherence to Antiretroviral Therapy Among Young People Living With Perinatally Acquired HIV in England.
The Journal of the Association of Nurses in AIDS Care (JANAC)
, 31
(5)
pp. 574-586.
10.1097/JNC.0000000000000171.
|
|
|
Walker, S;
Cox, E;
Revill, P;
Musiime, V;
Bwakura-Dangarembizi, M;
Mallewa, J;
Cheruiyot, P;
... Soares, M; + view all
(2020)
The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa.
Journal of the International AIDS Society
, 23
(3)
, Article e25469. 10.1002/jia2.25469.
|
|
2019
|
Haddow, LJ;
Godi, C;
Sokolska, M;
Cardoso, MJ;
Oliver, R;
Winston, A;
Stöhr, W;
... Jäger, HR; + view all
(2019)
Brain Perfusion, Regional Volumes, and Cognitive Function in Human Immunodeficiency Virus–positive Patients Treated With Protease Inhibitor Monotherapy.
Clinical Infectious Diseases
, 68
(6)
pp. 1031-1040.
10.1093/cid/ciy617.
|
|
Milinkovic, A;
Berger, F;
Arenas-Pinto, A;
Mauss, S;
(2019)
Reversible effect on lipids by switching from
tenofovir disoproxil fumarate to tenofovir
alafenamide and back.
AIDS
, 33
(15)
pp. 2387-2391.
10.1097/QAD.0000000000002350.
|
|
Shi, Y;
Thompson, J;
Walker, A;
PATON, NI;
Cheung, YB;
(2019)
Mapping the Medical Outcomes Study HIV Health Survey (MOS-HIV) to the EuroQoL 5 Dimension (EQ-5D-3L) utility index.
Health and Quality of Life Outcomes
, 17
, Article 83. 10.1186/s12955-019-1135-8.
|
|
|
Suonpera, E;
Matthews, R;
Milinkovic, A;
Arenas-Pinto, A;
(2019)
Risky Alcohol Consumption and Associated Health Behaviour Among HIV-Positive and HIV-Negative Patients in a UK Sexual Health and HIV Clinic: A Cross-Sectional Questionnaire Study.
AIDS and Behavior
, 24
pp. 1717-1726.
10.1007/s10461-019-02714-2.
|
|
Thompson, JA;
Kityo, C;
Dunn, D;
Hoppe, A;
Ndashimye, E;
Hakim, J;
Kambugu, A;
... Paton, NI; + view all
(2019)
Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial.
Clinical Infectious Diseases
, 68
(7)
pp. 1184-1192.
10.1093/cid/ciy589.
|
|
White, E;
Dunn, DT;
Desai, M;
Gafos, M;
Kirwan, P;
Sullivan, AK;
Clarke, A;
... PROUD study group; + view all
(2019)
Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial.
Sexually Transmitted Infections
, 95
(6)
pp. 449-454.
10.1136/sextrans-2018-053808.
|
|
2018
|
Arenas-Pinto, A;
Grund, B;
Sharma, S;
Martinez, E;
Cummins, N;
Fox, J;
Klingman, KL;
... INSIGHT START study group, .; + view all
(2018)
Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.
Clinical Infectious Diseases
10.1093/cid/ciy051.
(In press).
|
|
Dharan, NJ;
Neuhaus, J;
Rockstroh, JK;
Peters, L;
Gordin, F;
Arenas-Pinto, A;
Emerson, C;
... INSIGHT START Study Group; + view all
(2018)
Benefit of early versus deferred antiretroviral therapy on progression of liver fibrosis among people with HIV in the START randomized trial.
Hepatology
10.1002/hep.30296.
(In press).
|
|
Dunn, DT;
Stöhr, W;
Arenas-Pinto, A;
Tostevin, A;
Mbisa, JL;
Paton, NI;
or the Protease Inhibitor Monotherapy Versus Ongoing Triple Ther, .;
(2018)
Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy.
Journal of Clinical Virology
, 101
pp. 63-65.
10.1016/j.jcv.2018.02.003.
|
|
|
Le Prevost, M;
Arenas-Pinto, A;
Melvin, D;
Parrott, F;
Foster, C;
Ford, D;
Evangeli, M;
... AALPHI Steering Committee, .; + view all
(2018)
Anxiety and depression symptoms in young people with perinatally acquired HIV and HIV affected young people in England.
AIDS Care
, 30
(8)
pp. 1040-1049.
10.1080/09540121.2018.1441972.
|
|
|
Post, FA;
Szubert, AJ;
Prendergast, AJ;
Johnston, V;
Lyall, H;
Fitzgerald, F;
Musiime, V;
... Pett, SL; + view all
(2018)
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
Clinical Infectious Diseases
, 66
(S2)
S132-S139.
10.1093/cid/cix1141.
|
|
|
Siika, A;
McCabe, L;
Bwakura-Dangarembizi, M;
Kityo, C;
Mallewa, J;
Berkley, J;
Maitland, K;
... Gibb, DM; + view all
(2018)
Late presentation with HIV in Africa: phenotypes, risk and risk stratification in the REALITY trial.
Clinical Infectious Diseases
, 66
(S2)
S140-S146.
10.1093/cid/cix1142.
|
|
Wright, EJ;
Grund, B;
Robertson, KR;
Cysique, L;
Brew, BJ;
Collins, GL;
Poehlman-Roediger, M;
... INSIGHT START Neurology Substudy Group; + view all
(2018)
No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts.
AIDS
, 32
(8)
pp. 985-997.
10.1097/QAD.0000000000001778.
|
2017
|
Arenas-Pinto, A;
Stöhr, W;
Clarke, A;
Williams, I;
Beeching, NJ;
Minton, J;
Lee, V;
(2017)
Evaluation of CSF virological escape in patients on long-term PI monotherapy.
Antiviral Therapy
, 22
pp. 535-538.
10.3851/IMP3146.
|
|
Hakim, J;
Musiime, V;
Szubert, AJ;
Mallewa, J;
Siika, A;
Agutu, C;
Walker, S;
... Gibb, DM; + view all
(2017)
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.
New England Journal of Medicine
, 377
(3)
pp. 233-245.
10.1056/NEJMoa1615822.
|
|
Hakim, JG;
Thompson, J;
Kityo, C;
Hoppe, A;
Kambugu, A;
van Oosterhout, JJ;
Lugemwa, A;
... Europe Africa Research Network for Evaluation of Second-line The; + view all
(2017)
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial.
Lancet Infectious Diseases
, 18
(1)
pp. 47-57.
10.1016/S1473-3099(17)30630-8.
|
|
|
Hoppe, A;
Guilano, M;
Lugemwa, A;
Thompson, J;
Floridia, M;
Walker, AS;
Senoga, I;
... Paton, NI; + view all
(2017)
HIV-1 viral load and resistance in genital secretions in patients taking protease-inhibitor-based second-line therapy in Africa.
Antiviral Therapy
10.3851/IMP3200.
(In press).
|
|
Milinkovic, A;
Benn, P;
Arenas-Pinto, A;
Brima, N;
Copas, A;
Clarke, A;
Fisher, M;
... MiPEP Trial Team, .; + view all
(2017)
Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial).
Journal of Antimicrobial Chemotherapy
, 72
(6)
pp. 1760-1768.
10.1093/jac/dkx062.
|
|
Paton, NI;
Kityo, C;
Thompson, J;
Nankya, I;
Bagenda, L;
Hoppe, A;
Hakim, JG;
... Walker, AS; + view all
(2017)
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial.
The Lancet HIV
, 4
(8)
e341-e348.
10.1016/S2352-3018(17)30065-6.
|
|
2016
|
Arenas-Pinto, A;
Stöhr, W;
Jäger, HR;
Haddow, L;
Clarke, A;
Johnson, M;
Chen, F;
... PIVOT Neurocognitive sub-study Team, .; + view all
(2016)
Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT Trial.
Clinical Infectious Diseases
, 63
(2)
pp. 257-264.
10.1093/cid/ciw279.
|
|
Arenas-Pinto, A;
Thompson, J;
Musoro, G;
Musana, H;
Lugemwa, A;
Kambugu, A;
Mweemba, A;
... Paton, NI; + view all
(2016)
Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial.
Journal of Neurovirology
, 22
(1)
pp. 104-113.
10.1007/s13365-015-0374-7.
|
|
Baker, JV;
Hullsiek, KH;
Engen, NW;
Nelson, R;
Chetchotisakd, P;
Gerstoft, J;
Jessen, H;
... INSIGHT START Arterial Elasticity Substudy Team, .; + view all
(2016)
Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial.
Open Forum Infectious Diseases
, 3
(4)
10.1093/ofid/ofw213.
|
|
|
Dolling, DI;
Desai, M;
McOwan, A;
Gilson, R;
Clarke, A;
Fisher, M;
Schembri, G;
... PROUD Study Group, .; + view all
(2016)
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis.
Trials
, 17
(163)
10.1186/s13063-016-1286-4.
|
|
|
Judd, A;
Le Prevost, M;
Melvin, D;
Arenas-Pinto, A;
Parrott, F;
Winston, A;
Foster, C;
... Adolescents and Adults Living With Perinatal HIV (AALPHI) Steeri, .; + view all
(2016)
Cognitive Function in Young Persons With and Without Perinatal HIV in the AALPHI Cohort in England: Role of Non-HIV-Related Factors.
Clinical Infectious Diseases
, 63
(10)
pp. 1380-1387.
10.1093/cid/ciw568.
|
|
Kambugu, A;
Thompson, J;
Hakim, J;
Tumukunde, D;
van Oosterhout, JJ;
Mwebaze, R;
Hoppe, A;
... EARNEST Trial Team; + view all
(2016)
Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa: Analyses From the EARNEST Trial.
JAIDS Journal of Acquired Immune Deficiency Syndromes
, 71
(5)
pp. 506-513.
10.1097/QAI.0000000000000898.
|
|
Oddershede, L;
Walker, S;
Stöhr, W;
Dunn, DT;
Arenas-Pinto, A;
Paton, NI;
Sculpher, M;
(2016)
Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial.
Pharmacoeconomics
, 34
(8)
pp. 795-804.
10.1007/s40273-016-0396-x.
|
|
Paton, NI;
Stöhr, W;
Oddershede, L;
Arenas-Pinto, A;
Walker, S;
Sculpher, M;
Dunn, DT;
(2016)
The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection.
Health Technology Assessment
, 20
(21)
10.3310/hta20210.
|
|
Stohr, W;
Dunn, DT;
Arenas-Pinto, A;
Orkin, C;
Clarke, A;
Williams, I;
Johnson, M;
... Paton, NI; + view all
(2016)
Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy.
AIDS
, 30
(17)
pp. 2617-2624.
10.1097/QAD.0000000000001206.
|
2015
|
Arenas-Pinto, A;
Milinkovic, A;
Peppa, D;
McKendry, A;
Maini, M;
Gilson, R;
(2015)
Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study.
BMC Infect Dis
, 15
(1)
, Article 138. 10.1186/s12879-015-0889-9.
|
 |
|
Paton, NI;
Stöhr, W;
Arenas-Pinto, A;
Fisher, M;
Williams, I;
Johnson, M;
Orkin, C;
... Dunn, DT; + view all
(2015)
Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial.
Lancet HIV
, 2
(10)
e417-e426.
10.1016/S2352-3018(15)00176-9.
|
|
2014
|
Arenas-Pinto, A;
Winston, A;
Stöhr, W;
Day, J;
Wiggins, R;
Quah, SP;
Ainsworth, J;
... PIVOT Trial Team, .; + view all
(2014)
Neurocognitive function in HIV-infected patients: comparison of two methods to define impairment.
PLoS One
, 9
(7)
, Article e103498. 10.1371/journal.pone.0103498.
|
|
|
Paton, NI;
Kityo, C;
Hoppe, A;
Reid, A;
Kambugu, A;
Lugemwa, A;
van Oosterhout, JJ;
... Mugyenyi, P; + view all
(2014)
Assessment of second-line antiretroviral regimens for HIV therapy in Africa.
The New England Journal of Medicine
, 371
234 - 247.
10.1056/NEJMoa1311274.
|
|
2013
|
Efsen, AMW;
Panteleev, AM;
Grint, D;
Podlekareva, DN;
Vassilenko, A;
Rakhmanova, A;
Zeltina, I;
... Kirk, O; + view all
(2013)
TB Meningitis in HIV-Positive Patients in Europe and Argentina: Clinical Outcome and Factors Associated with Mortality.
BIOMED RESEARCH INTERNATIONAL
, 2013
(ARTN 373)
10.1155/2013/373601.
|
|
|
Podlekareva, DN;
Grint, D;
Post, FA;
Mocroft, A;
Panteleev, AM;
Miller, RF;
Miro, JM;
... Kirk, O; + view all
(2013)
Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients.
The International Journal of Tuberculosis and Lung Disease
, 17
(2)
pp. 198-206.
10.5588/ijtld.12.0224.
|
|
Winston, A;
Arenas-Pinto, A;
Stoehr, W;
Fisher, M;
Orkin, CM;
Aderogba, K;
De Burgh-Thomas, A;
... Team, PIVOTT; + view all
(2013)
Neurocognitive Function in HIV Infected Patients on Antiretroviral Therapy.
PLOS ONE
, 8
(4)
, Article e61949. 10.1371/journal.pone.0061949.
|
|
